Skip to content

Comparison of the safety and clinical efficacy of multi-center prospective laparoscopic sleeve gastrectomy and sleeve gastrectomy plus jejunojejunal bypass

Comparison of the safety and clinical efficacy of laparoscopic sleeve gastrectomy and sleeve gastrectomy plus jejunojejunal bypass: a multicenter, prospective randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044372
Enrollment
Unknown
Registered
2021-03-17
Start date
2021-09-01
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Experimental group:LSG+JJB
control group:LSG

Sponsors

Guangdong Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. BMI >=35 kg / m2; 2. Age 16-65 years old; 3. ECOG scores 0-1; 4. Sign informed consents; 5. The waist circumference of male is more than 90cm and that of female is more than 85cm.

Exclusion criteria

Exclusion criteria: 1. Patients lost in 1 year follow-up; 2. Accept modified surgery or switch to other weight loss surgery; 3. Mental retardation or immaturity, uncontrollable behavior, and inability to understand the risks, actual benefits, and compliance requirements of each plan; 4. Drug or alcohol abuse or mental illness beyond control; 5. Pregnancy; 6. Gastrointestinal surgery including stomach, small intestine, large intestine, bile duct, pancreas, spleen and trauma (except hemorrhoidectomy, herpes and appendectomy); 7. Contraindications for severe gastrointestinal diseases or major abdominal surgery: severe gastroesophageal reflux disease, large hiatal hernia, severe intestinal adhesion, malabsorbent inflammatory bowel disease (Crohn's disease or ulcerative colitis), etc.; 8. Use the study treatment or participate in any other clinical trial within 3 months; 9. Plan to move out of China or lose follow-up patients in the next year; 10. Other researchers think that patients are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Weight;Height;Postoperative complications;Excessive Weight Loss%;

Secondary

MeasureTime frame
LDL-C;HDL-C;Nutrition metabolism index;Total weight loss%;HbA1c;fast blood glucose;TC;TG;

Countries

China

Contacts

Public ContactWang Junjiang

Guangdong Provincial People's Hospital

sywangjunjiang@scut.edu.cn+86 13711657200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026